Pharmaceuticals and Life Sciences
Browse through stories in the life sciences, pharmaceuticals, and biotechnology.
The Art of the Fail: Lessons from the Trumpcare Debacle
As far as daytime dramas go, the the White House Administration’s ongoing challenges in passing its healthcare bill continue to dominate the news and make for “must-see” TV. After years... [Read More]
Prognosis Positive: Pharma and Biotech M&A Outlook
Dealmaking activity in the pharmaceutical and biotechnology industries remained strong in 2016, in contrast to M&A levels in many other sectors. [Read More]
How to Strengthen Pharma Alliances Using Virtual Data Rooms
This case study explains how a virtual data room for pharma alliances enables the alliance to operate with an integrated process. [Read More]
What the failed Pfizer-Allergan deal means for the future of tax inversions
Tax inversions are still legal, but are they still on the way out? Here's what the failed Pfizer-Allergan deal showed us. [Read More]
SUBSCRIBE TODAY
Get TOUCHPOINT stories delivered straight to your inbox.
Monoclonal Antibodies Continue to Drive Biotech Investment
Monoclonal antibodies represent one of the most successful therapeutic drug classes, attracting billions of investment dollars for the biotech industry. [Read More]
